Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Uniform Quality Standards for a Quarter of a Century

Published: Wednesday, February 27, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
SCHOTT Tubing has been publishing technical delivery specifications for pharmaceutical tubing for 25 years.

The international technology group SCHOTT has been documenting and publishing technical terms of supply for its glass tubing for use in pharmaceutical applications for 25 years now.

In fact, SCHOTT became the first company in the industry to provide its customers with exact specifications of the most important product parameters in 1988.

Since then, the ongoing improvements that have been made to its special glass tubing used to produce vials, syringes, cartridges and ampoules have been anchored in its terms of supply and thus made visible for its customers.

SCHOTT constantly strives to make improvements that flow into its quality standards to accommodate changing market demands, the needs of its customers and its own goal of providing its customers with maximum benefits.

A revised version of its technical delivery specifications is published about every three years.

“At SCHOTT Tubing, we have been setting the standards on manufacturing glass tubing for 25 years with our technical terms of supply. This means we are committed to constantly improving our production process and offer our customers the highest possible transparency and quality assurance,” says Jürgen Achatz, Global Sales Director for Pharmaceutical Tubing at SCHOTT.

In addition to a description of the products in which all of the characteristics of relevance to its customers are defined in great detail, the technical delivery specifications also include precisely determined tolerance ranges.

SCHOTT’s delivery specifications differ from its competitors’ technical terms of delivery not only in terms of their vast depth of detail and clarity.

The company also subjects its specification to further review by the Federal Association of the German Glass Industry.

The specialized group “Primary Packaging” discusses and evaluates the company’s standards, whereby the results flow directly into the final version of the delivery specifications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos